Clinical Trial Update: Role of Nasal Dysbiosis in Parkinson Disease

View source ↗

Summary

A completed clinical trial investigating the role of nasal microbiome imbalance (nasal dysbiosis) in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Institut Pasteur | Conditions: Parkinson Disease | Status: COMPLETED